- WKN: 904596
- ISIN: US8688612048
- Land: Russia
Nachricht vom 30.06.2021 | 13:11
'Surgutneftegas' PJSC: Information statement on the date as of which the persons entitled to exercise the rights vested in the issuer's equity securities are determined
'Surgutneftegas' PJSC (SGGD)
Information statement on the date as of which the persons entitled to exercise the rights vested in the issuer's equity securities are determined
Date as of which the persons entitled to exercise the rights vested in the issuer's securities are determined: 20 July 2021.
Rights vested in the issuer's securities in relation to which the date is set as of which the persons entitled to exercise these rights are determined:
- the right of holders of ordinary registered shares to receive an annual dividend;
- the right of holders of preference registered shares to receive an annual fixed dividend.
Identifying attributes of the issuer's securities in relation to which the date is set as of which the persons entitled to exercise the rights vested in such securities are determined
Class, category (type) and other identifying attributes of securities: ordinary and preference registered non-documentary shares.
Issues state registration numbers, state registration date and international securities identification number (ISIN):
ordinary shares: 1-01-00155-А dated 24 June 2003, RU0008926258;
preference shares: 2-01-00155-А dated 24 June 2003, RU0009029524.
Date and number of the minutes of the annual general shareholders' meeting of the issuer which adopted the resolution about the date of compiling the list of persons entitled to exercise the rights vested in the issuer's securities (the date of compiling the list of holders of the issuer's securities for the purpose of exercising the rights vested in the issuer's securities) or any other resolution being the basis for determining the said date: 30 June 2021, Minutes No. 32.
Website used by the issuer to disclose information:
Date of the event about which the statement is made: June 30 2021
 This Statement is a disclosure of insider information
|EQS News ID:||1213837|
|End of Announcement||EQS News Service|
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
03. Dezember 17:00 DAX: Der nächste Nackenschlag
03. Dezember 17:54 Börsenpunk: DAX - Angst ist zurück an den Märkten - jetzt trotzdem ...
03. Dezember 18:09 Alibaba, Tencent und Co: Kleiner Crash vorm Wochenende
03. Dezember 18:19 Musterdepot-Titel BHP: Es geht voran
03. Dezember 19:02 Dow Jones: Es hört nicht auf ...
News im Fokus
Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an
03. Dezember 2021, 07:03
FY 2020/2021 Financial Results
16. Dezember 2021
Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen
02. Dezember 2021